An observational study in Cardiac Arrest and Sepsis, sponsored by Seoul National University Hospital. Recruiting at 1 site in Korea, Republic of. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2023-11-24.
Sponsored by Seoul National University Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Heart Arrest by Seoul National University Hospital — 4 open to participants now, 5 under way, none of them phase 3. Heart Arrest · Seoul National University Hospital.
Among the 12 studies in Heart Arrest by Seoul National University Hospital, this one is the only one that started in 2006, is one of 4 observational ones, and was the 2nd registered.
927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.
Browse Heart Arrest studies →4 of the 12 studies in Heart Arrest by Seoul National University Hospital are open now, in 1 country. Recruiting first, the newest first:
Seoul National University Hospital · Sites in Korea, Republic of
Ages 18–50 · Healthy volunteers
Seoul National University Hospital · Sites in Korea, Republic of
Ages 18+ · Healthy volunteers
Seoul National University Hospital · Sites in Korea, Republic of
Ages 20–80
By country, each count listing its studies:
Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.
This study: 16 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 1 started in 2006.
This study's planned enrollment of 500 is above the median of 200 across 376 observational studies indexed under Heart Arrest.
Median enrollment 150 across the 8 interventional studies, 272 across the 4 observational. Of the 6 that completed or were terminated, 1 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
Seoul National University Hospital is the lead sponsor of 1,903 studies on the registry; 276 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
1 of the studies in Heart Arrest by Seoul National University Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07363772Seoul National University HospitalEvaluation of Mixed Reality Cardiopulmonary Resuscitation Training | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 12 studies in Heart Arrest by Seoul National University Hospital, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The objective of this study is to find a new therapeutic strategy by investigating the serial serum samples of patients with sepsis or postresuscitation state.
Sepsis patients admitted to ICU Postresuscitation patients admitted to ICU
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Adults (age over 16 years old) who have survived from nontraumatic cardiac arrest and admitted to ICU.
Adults (age over 16 years old) who satisfy the sepsis criteria (SIRS\>=2 and infection is suspected for a cause) and admitted to the ICU.
1-month mortality
All cause mortality within 1-month
Time frame: 1 month
Hospital mortality
All cause mortality during hospitalization
Time frame: until hospital discharge, an expected average of 2 weeks
ICU length of stay
Time frame: Until ward transfer or discharge, an expected average of 7 days
Favorable neurologic outcome
Favorable neurologic outcome is used for outcome measure in postresuscitation patients only. Favorable neurologic outcome means cerebral performance category 1 and 2. This outcome is measured at discharge and 6-month after admission.
Time frame: at discharge, an expected average of 2 weeks and at 6-month
The record gives a start of Jul 2006, a primary completion of Dec 2028 and a completion of Dec 2028. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital →